Hoe kunnen we moleculair diagnostische mogelijkheden, zoals tumor sequencing, optimaal benutten voor de behandeling van kanker?

In order to improve the success of treatment and to further individualize such treatment, better insight is needed into the molecular, (epi)genetic and immunological processes that are implicated in the transformation and malignant outgrowth of normal (stem) cells to malignant cancer cells.